INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)
The Company was notified today that Ms Caroline Gulliver, a non-executive Director of the Company, purchased 2,000 Ordinary 25p shares in the capital of the Company on 05 August 2021 at a price of 723.8955 pence per Ordinary share. As a result of this purchase, Ms Gulliver's aggregate holding of shares in the Company is 9,500 Ordinary shares, representing 0.02% of the Company's issued share capital.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||
| a) | Name | Caroline Gulliver | |||||
| 2 | Reason for the notification | ||||||
| a) | Position/status | Director | |||||
| b) | Initial notification/Amendment | Initial notification | |||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
| a) | Name | International Biotechnology Trust plc | |||||
| b) | LEI | 213800N1QUJ744P76D11 | |||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares
GB0004559349 | |||||
| b) | Nature of the transaction | Share purchase | |||||
| c) | Price(s) and volume(s) |
| |||||
| d) | Aggregated information
|
N/A
N/A | |||||
| e) | Date of the transaction | 05 August 2021 | |||||
| f) | Place of the transaction | London Stock Exchange | |||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
